Ken Griffin’s ProShares UltraShort Health Care RXD Stock Holding History

Ken Griffin’s Portfolio RXD Stock Details RXD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-267,375	Closed	-$27.4M	–	7685
2016 Q2	$27.4M	Buy	267,375 +35,450	+15%	+$6.83M	0.03%	598
2016 Q1	$22.2M	Buy	231,925 +44,050	+23%	+$9.72M	0.03%	689
2015 Q4	$22.9M	Sell	187,875 -52,000	-22%	-$10.6M	0.03%	771
2015 Q3	$32.5M	Sell	239,875 -2,675	-1%	-$540K	0.03%	620
2015 Q2	$34.2M	Buy	242,550 +200,175	+472%	+$39.8M	0.03%	681
2015 Q1	$24.6M	Sell	42,375 -15,025	-26%	-$3.29M	0.02%	862
2014 Q4	$36.1M	Sell	57,400 -19,106	-25%	-$5.01M	0.04%	633
2014 Q3	$55.1M	Buy	76,506 +13,750	+22%	+$4.26M	0.06%	371
2014 Q2	$44.1M	Buy	62,756 +13,468	+27%	+$4.81M	0.05%	439
2014 Q1	$42.1M	Buy	+49,288	New	+$18.6M	0.05%	461

Other funds holding RXD

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ken Griffin's RXD Position: Q4 2022 in Review

Ken Griffin sold out of ProShares UltraShort Health Care (RXD) in Q4 2022, closing a stake of 10,802 shares — an estimated $326K sold.

Ken Griffin first reported a position in RXD in Q1 2019 and held it in 6 quarters. The position peaked at $540K in Q1 2020. 3 funds tracked by Wall St. Rank hold RXD as of Q4 2022.

Ken Griffin reported no remaining ProShares UltraShort Health Care position as of Q4 2022 after selling out during the quarter.
Ken Griffin sold 10,802 ProShares UltraShort Health Care shares in Q4 2022, an estimated $326K.
Ken Griffin first reported a position in ProShares UltraShort Health Care in Q1 2019 and held it in 6 quarters.
Ken Griffin's ProShares UltraShort Health Care position peaked at $540K in Q1 2020.
3 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.